NJ Mulls New Compounding Pharmacy Law Following Outbreak

Law360, New York (November 21, 2012, 5:59 PM EST) -- Responding to a deadly meningitis outbreak that includes dozens of cases in New Jersey, state lawmakers are now looking to crack down on compounding pharmacies that prepare customized prescription drugs for patients.

The outbreak, which has claimed the lives of 34 people nationwide, has been traced to contaminated spinal steroid injections distributed from the Massachusetts facility of the New England Compounding Center.

The “Compounding Pharmacy Quality Assurance Act” that New Jersey legislators introduced Monday would require that compounding pharmacies in the state be accredited by the...
To view the full article, register now.